Insmed Incorporated

Equities

INSM

US4576693075

Real-time Estimate Cboe BZX Other stock markets 10:36:15 15/05/2026 pm IST			5-day change	1st Jan Change
108.76 ^USD	-5.93%		+8.09%	-37.06%

13/05	Insmed Incorporated Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 01:40 PM
08/05	Insmed Stock Sell-off is Overdone as Underlying Metrics Appear Positive, RBC Says	MT

Transcript : Insmed Incorporated Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 09

Published on 06/11/2025 at 11:05 pm IST - Modified on 06/12/2025 at 12:05 am IST

S&P Capital IQ

Presenter Speech
Unknown Analyst (Analysts)

Good morning, everyone. Thanks so much for joining us. I'm really pleased to be joined this morning by Will Lewis, Chair and CEO of Insmed. Will, thanks so

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Insmed Incorporated

13/05	Insmed Incorporated Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 01:40 PM
08/05	Insmed Stock Sell-off is Overdone as Underlying Metrics Appear Positive, RBC Says	MT
08/05	RBC Cuts Price Target on Insmed to $205 From $220, Keeps Outperform Rating	MT
07/05	Insmed Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
07/05	Insmed Incorporated, Q1 2026 Earnings Call, May 07, 2026
07/05	Insmed Q1 Loss Narrows, Revenue Rises; Shares Down Pre-Bell	MT
07/05	Earnings Flash (INSM) Insmed Incorporated Reports Q1 Revenue $306.0M, vs. FactSet Est of $300.8M	MT
07/05	Earnings Flash (INSM) Insmed Posts Q1 Net Product Revenue $306M, vs. FactSet Est of $300.8M	MT
07/05	Earnings Flash (INSM) Insmed Posts Q1 Loss $0.76 a Share, vs. FactSet Est of $0.96 Loss	MT
07/05	Insmed Incorporated Reiterates Earnings Guidance for 2026	CI
07/05	Insmed Insider Sold Shares Worth $1,469,442, According to a Recent SEC Filing	MT
04/05	Insmed Incorporated to Present Data Across Its Respiratory Portfolio, Including Late-Breaking Arikayce Results from Phase 3B Encore Study, At the American Thoracic Society International Conference 2026	CI
04/05	Weekly Earnings Calendar: Palantir, AMD, AXA and Engie in the Spotlight
04/05	Weekly Earnings Calendar: Palantir, AMD, AXA and Engie in the Spotlight
27/04	Zambon Spa, Insmed Incorporated, Novabiotics, Haisco Pharmaceutical Group, Armata Pharmaceuticals, Chiesi Farmaceutici, Csl Behring, and Others Announces Brensocatib Clinical Progress and Approvals for Non-Cystic Fibrosis Bronchiectasis	CI